ENDRA Life Sciences Inc logo

ENDRA Life Sciences Inc NDRA

Market Closed
20 Nov, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 07
+0.36
+7.64%
$
2.58M Market Cap
- P/E Ratio
0% Div Yield
243,100 Volume
-1.41 Eps
$ 4.71
Previous Close
Day Range
4.48 6.25
Year Range
4.01 4,882.5

NDRA Chart

ENDRA Life Sciences Inc Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. Francois Michelon CEO
NASDAQ (CM) Exchange
US29273B1044 ISIN
US Country
21 Employees
- Last Dividend
9 Dec 2022 Last Split
9 May 2017 IPO Date

Overview

ENDRA Life Sciences Inc. is a pioneering company focused on enhancing the capabilities of clinical diagnostic ultrasound through advanced technology. Based in Ann Arbor, Michigan, and incorporated in 2007, ENDRA Life Sciences strives to revolutionize the way diseases are diagnosed and treated, with a special focus on nonalcoholic fatty liver disease. The company has made significant strides in the field through its collaboration with General Electric Company, showcasing its commitment to integrating cutting-edge research and development into practical medical applications.

Products and Services

ENDRA Life Sciences Inc. offers a range of innovative diagnostic imaging technologies aimed at improving patient care through more accurate and non-invasive diagnostics. These technologies include:

  • Thermo-Acoustic Enhanced Ultrasound Technology: This flagship technology utilizes sound waves that interact with body tissues, organs, and blood. The interaction generates images that can assist in the diagnosis and treatment of various conditions, including nonalcoholic fatty liver disease. This technology stands out for its ability to provide more detailed images compared to traditional ultrasound, offering significant advancements in understanding tissue composition, measuring temperature changes, conducting vascular imaging, and assessing tissue perfusion.
  • Computed Tomography (CT): ENDRA Life Sciences harnesses the power of CT scans to create detailed images of the inside of the body. CT scans are particularly useful in diagnosing cancers, investigating signs of heart disease, and detecting internal bleeding or broken bones. The technology offers a non-invasive way to guide treatment plans and understand the internal workings of the human body in greater detail.
  • Magnetic Resonance Imaging (MRI): MRI is another critical tool in ENDRA’s arsenal, providing detailed images of the body’s organs and tissues using magnetic fields and radio waves. This technology is invaluable for diagnosing a wide range of conditions, from brain and spinal cord injuries to tumors and diseases affecting the joints. Its non-invasive nature and the detailed images it produces make MRI an essential tool in modern medicine.
  • Ultrasound: Beyond its enhanced ultrasound technology, ENDRA also offers traditional ultrasound imaging, a versatile diagnostic method used to capture live images of the internal structures of the body. It is widely used in various medical scenarios, such as monitoring the health of fetuses during pregnancy, diagnosing gallbladder disease, and evaluating other conditions that require visualization of soft tissue structures.

Contact Information

Address: 3600 Green Court, Ann Arbor, MI, United States, 48105-1570
Phone: 734 335 0468